This is an Open Access article licensed under the terms of the Creative Commons AttributionNonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only. This study evaluated the chemopreventive effect of a T. polycephalum hexane extract (TPHE) using in in vivo and in vitro models. Methods and Results: Five groups of rats: normal control, cancer control, TPHE low dose, TPHE high dose and positive control (tamoxifen) were used for the in vivo study. Histopathological examination showed that TPHE significantly suppressed the carcinogenic effect of LA7 tumour cells. The tumour sections from TPHE-treated rats demonstrated significantly reduced expression of Ki67 and PCNA compared to the cancer control group. Using a bioassay-guided approach, the cytotoxic compound of TPHE was identified as a tricyclic sesquiterpene lactone, namely, 8β-hydroxyl-4β, 15-dihydrozaluzanin C (HDZC). Signs of early and late apoptosis were observed in MCF7 cells treated with HDZC and were attributed to the mitochondrial intrinsic pathway based on the up-regulation of Bax and the down-regulation of Bcl-2. HDZC induced cell cycle arrest in MCF7 cells and increased the expression of p21 and p27 at the mRNA and protein levels. Conclusion: This results of this study substantiate the anticancer effect of TPHE and highlight the involvement of HDZC as one of the contributing compounds that act by initiating mitochondrial-mediated apoptosis.
Experimental design and animal treatment
A total of thirty female rats were randomly divided into five different groups (n=6). The animals were classified as group A-E. Group A consisted of the non-treatment LA7-induced non-treated tumour control animals, group B consisted of animals treated with a low dose (250 mg) of TPHE, group C consisted of animals treated with a high dose (500 mg) of TPHE, group D consisted of animals treated with tamoxifen, and group E consisted of animals that were the normal control group. For treatment, TPHE and tamoxifen were dissolved in Tween-20 and fed orally to the rats once a day for 6 weeks using gastric tubes two weeks before LA7 cell injection. The body weight of each rat was recorded weekly. At the end of the experiment, all of the rats were sacrificed via CO 2 asphyxiation. Mammary tissue samples were obtained, washed twice with ice-cold PBS and kept for histopathological analyses.
Induction of mammary gland tumours
After reaching 90% of confluence, LA7 cells grown in DMEM medium were removed from the medium and the monolayer was washed with PBS. The cells were then detached from the culture flask by adding trypsin (EDTA). The cells were placed into a falcon tube and centrifuged at 1800 rpm for 5 min at 4 °C and then washed with PBS. The cells were then counted using a haemocytometer. The cell suspensions were used within one h of harvesting. LA7 cell suspensions containing 5 × 10 6 cells in 300 μl of PBS were injected subcutaneously into the left flank mammary fat pad of each rat using a tuberculin syringe and a 21-gauge needle.
Tumour growth
To monitor mammary tumour development, the diameters of the tumours were measured and recorded vertically and horizontally. Tumour volume (V) was calculated by the modified ellipsoidal formula: V= (ab 2 )/2, where 'a' and 'b' are the longest and shortest diameter of the tumour, respectively.
Histopathological examination
The breast tumours were inserted in blocks, fixed with 10% buffered formalin and embedded in paraffin. The blocks were sectioned into approximately 5 µm thick sections, which were then stained with Hematoxylin & Eosin (H & E). The stained sections were then evaluated and images were captured using light microscopy (Olympus BX51, Tokyo, Japan) by a histopathologist who was blinded to the treatment assignments.
TUNEL assay
The TUNEL assay was used to measure fragmented DNA in apoptotic cells by combining flourescein-12-dUTP (a) at 3′-OH DNA ends using the terminal recombinant deoxynucleotidyl transferase enzyme (rTdT). The mammary tumour tissues were subjected to the DeadEnd Fluorometric TUNEL system according to the manufacturer's instructions (Promega Inc., Madison, WI, USA). Then, the sections were evaluated and 
Immunohistochemistry
The paraffin sections were fixed with formaldehyde and were then subjected to graded alcohol dehydration and embedded in paraffin. The sections were incubated with primary antibodies against PCNA, Ki67, Bax, Bcl-2, Caspase 3, p21, p27 and p53 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and were incubated with a biotinylated secondary antibody. Colorimetric detection was performed using a DAB detection kit (Dako, Glostrup, Denmark). Images were captured using a light microscope (Olympus BX51).
General experimental procedures
Column Chromatography (CC) was run on silica gel 60 (40-63 μm), while TLC was performed on aluminium and glass plates pre-coated with silica gel 60 F 254 (Merck, Germany). UV spectra were recorded on a Shimadzu UV-160A spectrophotometer using MeOH as a solvent, and 1H NMR and 13 C NMR spectra were collected (JEOL JNM-FX500). The separation step was performed using HPLC with a PDA detector and an ODS, C-18 column (Phenomenex). MS was obtained using an Agilent 6530 and FT-IR: Perkin-Elmer RX 1 (Fourier transform infra-red) spectrometer was utilized to analyse the IR at frequencies of 4000-400 cm
Cell viability analysis
Cell viability analysis was carried out using a MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium) assay as previously described [17] . Briefly, cells in the exponential growth phase were treated with HDZC at different concentrations (0.39 µg/mL to 50 µg/mL) in 96-well plates and were incubated for 12, 24 and 48 h. Cells treated with tamoxifen (Sigma) were used as the positive controls. After incubation, MTT dye (5 mg/mL, 50 μl, Sigma) was added to each well, and the resulting formazan crystals were dissolved using DMSO (200 μl). Absorbance was measured at 570 nm using a microplate reader (Asys UVM340, Eugendorf, Austria), and the anti-proliferative potential of HDZC was expressed as the IC 50 value.
Bioassay-guided fractionation and isolation of the compounds
Hexane crude extract (4.6 g) was chromatographed on a silica gel 60 column (40-63 μm particle size) and eluted sequentially with Hexane/CH 2 Cl 2 mixtures (70:30 → 0:100). Eluates were collected, and those displaying similar R f values on TLC were pooled to yield ten fractions (F 1 -F 10 ). Fraction F 9 (0.53 g) was further purified by micro column chromatography using CH 2 Cl 2 / MeOH (80:20 → 0:100) and was separated into 6 and 4 sub fractions (F 91 -F 96 ) and (F 951 -F 954 ) (Fig. 7) . The separation of fraction F 953 (0.23 g) by preparative HPLC with a ODS C-18 4.6 x250 mm, 5.0 μm, 70 A column and the mobile system of (50-100% ACN-H 2 O, detection at 210 nm, 7 mL/min) successively yielded a single chromatogram that was identified as 8β-hydroxyl-4β, 15-dihydrozaluzanin C 1 (1, 5 mg, 0.0025 %). This is the first time that 8β-hydroxyl-4β, 15-dihydrozaluzanin C 1 (Fig. 6 ) has been isolated from T. polycephalum. It was confirmed to be tricyclic sesquiterpene lactone by comparing NMR, mass and other physical properties with previously reported data [18] .
Characterization data
The white amorphous solids were characterized as follows: UV (MeOH), max , 271, 338 nm; IR (CHCl 3 ), Table 2) .
Cell cycle analysis
Cycle progression in the cells treated with HDZC was examined using flow cytometric analysis [19] . In brief, MCF7 cells (5 × 10 4 cells/mL), at the exponential phase of growth, were treated with HDZC at the 
Annexin V-FITC analysis
Flow cytometric analysis of early and late apoptosis was investigated using Annexin-V-FITC/PI staining [20] . Briefly, after treating the cells with HDZC at IC 50 concentrations for 12, 24 and 48 h, MCF7 cells were harvested and washed twice with PBS. The cells were suspended in Annexin-V binding buffer (BD Biosciences) and were stained with Annexin V-FITC and PI (BD Biosciences) for 30 min in the dark. The fluorescent intensity was analysed via quadrant statistics for early and late apoptotic signs using a BD FACSCanto II flow cytometer.
Caspase bioluminescent analysis
The assay was carried out using Caspase-Glo 7 and Caspase-Glo 9 commercial kits (Promega, Madison, WI, USA) as previously described [21] . Briefly, MCF7 cells (1 × 10 5 cells/mL) were seeded onto a white 96-well microplate and were treated with HDZC at an IC 50 concentration followed by incubation for 3, 6, 12, 24 and 48 h. The cells were then supplemented with caspase-Glo reagents according to the manufacturer's instructions. The bioluminescent activity of the caspases was measured using the Infinite-200 Pro luminescence microplate reader (Tecan, Männedorf, Switzerland).
Real-time Q-PCR analysis
The time-dependent mRNA expression of apoptotic related genes in treated breast cancer cells was examined using quantitative PCR analysis [22] . In brief, the RNeasy plus commercial kit (Qiagen, Valencia, CA, USA) was used to extract total RNA from MCF7 cells after treatment with the IC 50 concentration of HDZC. cDNA synthesis from extracted RNA was performed using an iScript cDNA synthesis kit (Bio-Rad, Hercules, CA, USA) according to the manufacturer's protocol. Q-PCR analysis was performed with SsoFast EvaGreen Supermix (Bio-Rad) on a StepOne PLUS real-time PCR machine (Applied Biosystems, Foster City, CA, USA). The mRNA expression of genes was expressed after normalization with the β-actin housekeeping gene. The IDs for Solaris Gene Expression (Thermo Fisher Scientific, Waltham, MA, USA) Assays used in this study are Bax: AX-003308-00-0100; Bcl-2: AX-003307-00-0100; Caspase-7: AX-004407-00-0100; Caspase-9: AX-003309-00-0100; p21: AX-003471-00-0100; p27: AX-003472-00-0100 and β-actin, AX-003451-00-0100.
Western blot analysis
A time-dependent western blot analysis was performed as previously described by Hajrezaie and colleagues with some modifications [23] . In brief, the total proteins were extracted from treated cells using Pierce cell lysis buffer (Rockford, IL, USA) according to the manufacturer's instructions. Extracted proteins (40 µg/mL) were separated by 10% SDS-PAGE and transferred to PVDF membrane (Bio-Rad). Casein (Pierce) was used to block the PVDF membrane prior to washing with TBST. The membrane was incubated overnight with specific primary antibodies, namely, Bax: 1:10,000 (Cat: sc-493); Bcl-2: 1:10,000 (Cat: sc-492); Caspase 7: 1:10,000 (Cat: sc-33773); Caspase 9: 1:10,000 (Cat: sc-7885); p21: 1:10,000 (Cat: sc-397); p27: 1:10,000 (Cat: sc-528) and β-actin, 1:10,000 (Cat: sc-7210) (Santa Cruz Biotechnology, Inc., CA, USA). After incubation, appropriate peroxidase-coupled secondary antibodies were applied to the blot and the detection of bands was carried out using the Fusion FX7 system (Vilber Lourmat, Germany).
Statistical analysis
Data from the in vivo study were reported as the means ± SEM of n animals per group. The in vitro results for at least three independent experiments were expressed as the mean value ± SEM, and the differences were considered to be significant at the *p<0.05 level. Statistical analysis was carried out using GraphPad prism (version 4.0 Graphpad software Inc., San Diego, CA, USA). Analyses of variance were performed using the one-way ANOVA procedure followed by Tukey's post hoc test. 
Results and Discussion
Tumour development, body weight, tumour size and volume Tumours appeared as early as 10 days after LA7 cell injections. The body weights, tumour volumes and tumour percentages (%) of treated and control animals are represented in Table 1 . There was a significant body weight decrease in the cancer control group compared with the normal control animals, however, the low dose did not show any significant changes in weight compared to the controls.
Tumours in group A were enlarged up to 2,137 ± 324 mm 3 ; however, a significant decrease appeared in the high TPHE doses (457 ± 132 mm treated groups compared with the tumour control group. The low dose of TPHE did not show a significant decrease in tumour size compared to the tumour control and tamoxifen group (1,781 ± 248 mm), but the high dose of TPHE was shown to significantly reduce the tumour size comparable to tamoxifen treatment. Based on our finding of the size of the tumour and the body weight of the animal, we can conclude the efficacy of TPHE in reducing tumour size, which is associated with increases in body weight (Table 1) . (Fig. 1) . Based on these results, we conclude that the development of the tumour was based on the invasive adenocarcinoma subtype with no tubular structure. In normal tissue, the duct was healthy and there was no sign of variation in size and shape; however, the untreated tumour showed a significant variation in the size and shape of the duct, followed by the disruption of the ductal structure (Fig. 1 ). Groups treated with high doses of TPHE had reduced mitotic events and smoothening of the tissue that led to the reorganization of the cells compared to the untreated group. However, normal rats treated with TPHE showed no changes in mammary gland morphology. Based on the morphology of the cells, the improved mammary gland structure was significantly more visible after treatment with high doses of TPHE and tamoxifen compared to the untreated cancer rats and there were no significant differences in the low dose treatment group.
Apoptosis
The TUNEL assay was used to determine whether inhibition of the tumour cells occurred through apoptosis. The tumour sections of the rats injected with breast cancer inducing LA7 showed significantly higher numbers of apoptotic cells after treatment with TPHE than the normal control and mammary tumour control rats. Indeed, the control groups showed very little or no obvious signs of apoptosis in the mammary glands (Fig. 2) . Apoptotic cells were apparent in mammary tumour sections of all of the high dose TPHE-and tamoxifen-treated rats (Fig. 2) .
Immunohistochemistry
The expression of cell nuclear antigen (PCNA) and Ki67 protein are closely associated to the proliferation of the tumour cells. The high levels of PCNA and Ki67 indicate an aggressive tumour prognosis. Immunohistochemical analysis of the cancer control group showed higher expressions of PCNA and Ki67 compared to the TPHE treatment groups. These findings demonstrate the promising chemopreventive Table 2 . NMR spectroscopic data (500 MHz, CDCl 3 ) for compound 1 (δ in ppm, J in Hz) Fig. 2 . Induced apoptosis of breast cancer cells as determined by the TUNEL assay. A) Control tumor tissue. B) Breast tissue from low dose of TPHE treatment group C) Breast tissue from high dose of TPHE treatment group. D) Breast tissue from tamoxifen treated group. Breast cancer tissue sections from the control and treatment group were subjected to the TUNEL assay. Tissue from the control group did not shows any significant changes in the color of the tissues While tissue from the high dose TPHE and tamoxifen treated groups showed a very high number of apoptotic cells. The low dose TPHE treated group did not show significant apoptotic activity. Magnification 40x.
potential of TPHE, which was proven by the reduced protein expressions of tumour markers (Fig. 3) .
Because the potency of TPHE in inducing apoptosis in breast cancer cells was previously reported to occur through the mitochondrial pathway [16] , we investigated the expression of Bax, Bcl-2, caspase 3, p53, p21 and p27 proteins, as these proteins are implicated in the induction of apoptosis through intrinsic apoptosis pathways. The microscopic observations of the slides in Fig. 4 demonstrate the significant differences between the TPHE high dose and tamoxifen-treated groups in comparison to the tumour control group. The results represent the up-regulation of Bax, p53 and caspase 3 proteins and the down-regulation of the expression of Bcl-2 proteins. The low dose TPHE treated group was not significantly different compared to the positive control group (Fig 4) . Immunohistochemical observations Fig. 5 revealed the up-regulation of these two proteins in the low and high TPHE dose groups, followed by up-regulation in the tamoxifen treated group. Programmed cell death can be triggered through p53 expression associated with a transcriptional modulator, which can be closely mediated by the suppression or activation of other gene transcriptions [24] . The function of p53 is also closely related to the ratio of Bax/Bcl-2 proteins [25] . Tumours with the loss of function of p53 are expected to have low levels of Bax and high levels of Bcl-2. In addition, the G 1 -S phase of cell cycle arrest can be closely mediated by the suppression or activation of the p53 gene, which has the ability to induce the cyclin-dependent kinase genes p21/p27. Our results showed the up-regulation of the Bax protein and the down regulation of the Bcl-2 protein after treatment with a high dose of TPHE, while the tumour control group had low expressions of Bax and high expressions of Bcl-2 protein (Fig. 4) , suggesting that apoptosis occurred through the mitochondrial pathway. The expression level of p53 was elevated in the high dose TPHE treatment group compared to the untreated control. The up-regulation of p21/p27 in the high dose TPHE treatment group compared to the normal control group could be due to an arrest in the cell cycle progression (Fig. 5) .
Sesquiterpene lactones
Sesquiterpene lactones, an extensive and diverse class of biologically active compounds, have been widely isolated from various plants belonging to the Asteraceae family [26] . Sesquiterpene lactones are a group of naturally occurring plant terpenoids representing crucial constituents of essential oils [27] . In recent years, numerous studies have demonstrated that different sesquiterpene lactones possess a notable anticancer potential [27, 28] . For instance, costunolide isolated from Saussurea lappa roots [29] , parthenolide isolated from Tanacetum parthenium [30] [31] [32] and helenalin isolated from Arnica species [33, 34] were reported to be anti-cancer sesquiterpene lactones. In this study, 8β-hydroxyl-4β, 15-dihydrozaluzanin C (Fig. 6) was isolated from T. polycephalum to assess its biological activity on human breast cancer cells.
HDZC selectively suppressed the growth of MCF7 cells
The antiproliferative effect of HDZC against a breast cancer cell line (MCF7) and a noncancer cell line (MCF10A) was screened using the MTT assay. As shown in Table 3 , HDZC [16] . Meanwhile, proliferation of normal cells (MCF10A) was affected by HDZC solely at higher concentrations.
HDZC induced G1 cell cycle arrest
Flow cytometry analysis of MCF7 treated with HDZC indicated significant increases of the cell population in the G 1 phase after 12, 24 and 48 h (Fig. 8) . Arrest of the cell cycle progression is an effective approach for inhibiting the proliferation of cancer cells [35] [36] [37] . PI dye binds to DNA molecules at all cell cycle stages when applied to apoptotic cells, and thereafter, the emitted fluorescent intensity representing the DNA content of the cells is measured using flow cytometry analysis. Fig. 8 demonstrates the cell cycle phase distribution in MCF7 cells specific to each phase after treatment with HDZC at the IC 50 concentration. Expression of the G 1 phase was most evident in the MCF7 cells treated with HDZC (12 h: 61.13%; 24 h: 62.64%; 48 h: 64.25%) relative to the control cells. The arrest of MCF7 cells at the G 1 phase was associated with a consequent reduction in the percentage of cells at the S and G 2 /M phases.
A previous study showed that costunolide sesquiterpene lactone induced G 1 cell cycle arrest in hormone dependent (LNCaP) and independent (PC-3 and DU-145) prostate cancer cells [38] . Similarly, parthenolide sesquiterpene, in combination with NS398, resulted in cell cycle arrest at the G 0 /G 1 phase in Hep3B, HepG2 and PLC human hepatocellular carcinoma cells [39] . Jang and co-workers reported a dose-dependent elevation in the sub G 1 populations of human renal carcinoma Caki cells treated with helenalin sesquiterpene [34] . Consistently, our findings showed that HDZC, like other sesquiterpene lactones, arrested the cell cycle of the breast cancer cell line at the G 1 phase.
HDZC induced apoptosis in MCF7 cells
The aforementioned results of the selective cytotoxic effect of HDZC towards MCF7 cells encouraged us to examine the early events of apoptosis. It has been well established 
that during early apoptosis, plasma membrane asymmetry is lost because of the phosphatidylserine externalization [40] . Cancer is generally defined as a disease of abnormal cell growth; therefore, disruption or deformity of the cell plasma membrane means losing the cell architecture, leading to the discontinuity of their life cycle. Annexin V-FITC/PI followed by flow cytometry analysis is a methodology that is applied to examine the integrity of the cell external membrane [41] . We observed MCF7 cell membrane leakage with double staining with different intensities in accordance to the phase of apoptosis. As shown in 11 . Q-PCR analysis of apoptosis-and cell cycle-associated molecules, viz. Bcl-2, Bax, caspase 9, caspase 7, p21 and p27. MCF7 cells were exposed to HDZC at IC 50 concentration for 12, 24 and 48 h. The mRNA expression of genes was represented after normalization with β-actin housekeeping gene. The data represent the means ± SEM of three independent experiments. *p<0.05 compared with the control group. Fig. 10 . Effect of HDZC on the activation of caspase 9 and caspase 7. The caspase 7 and 9 on MCF7 cells was determined using a bioluminescent analysis. MCF7 cells were treated with the vehicle 0.1% DMSO (control) for 48 h and HDZC (IC 50 concentration) for 3, 6, 12, 24 and 48 h. Caspase 9 and caspase 7 were significantly activated after 12, 24 and 48 h treatment. The data represent the means ± SEM of three independent experiments. *p<0.05 compared with the control group. Caspases, a family of cysteine proteases including at least 14 members, form a complex and energy-dependent cascade that executes apoptotic cells after a fatal insult [42] . The hierarchical organization of caspases generally consists of several initiator proteases (caspase 2, 8, 9, and 10), executioner or effector proteases (caspase 3, 6, and 7) and inflammatory proteases (caspase 1, 4, and 5) [43] . Caspase 9, in particular, is a key mediator of mitochondrial-mediated apoptosis, and the up-regulation of caspase 9 follows the upstream activation of caspase 7 prior to apoptosome formation and the fluctuation of the mitochondrial membrane potential [44] . To determine whether the induced apoptosis was caspase-mediated, we measured the activity of caspase 9 and caspase 7 in MCF7 cells using a bioluminescent analysis. Our studies indicated a significant time-dependent elevation of caspase 9 and caspase 7 (for example, the mRNA expression of caspase 9 and caspase 7 was 8.30 and 5.85-fold, respectively, after 48 h) after treatment with HDZC in comparison to the control group (Fig. 10) . However, the elevation of caspase 9 was higher than caspase 7, as observed in Fig. 11 . Western blot analysis also confirmed the time-dependent enhancement of the expression of caspase 9 and caspase 7 (Fig. 12) . Together, these results highlight the involvement of the intrinsic pathway of mitochondrial-derived apoptosis mediated by caspase 9 and caspase 7 dysregulation in MCF7 cells.
The effect of HDZC on Bax/Bcl-2 expression
Translocation of the pro-apoptotic Bax protein from the cytosol to the outer mitochondrial membrane and its oligomerization leads to changes in the mitochondrial membrane potential, both of which are associated with cytochrome c leakage [45] . On the other hand, the suppression of cytochrome c release is controlled by the anti-apoptotic Bcl-2 protein [46, 47] . Both the pro-apoptotic and anti-apoptotic proteins cause perturbations among mitochondrial-activated functions, such as those of caspase 9 [48] . Because HDZC elicited the ability to activate caspase 9, it was of interest to determine the possible role of the two proteins, Bax and Bcl-2, in neutralizing this effect. Hence, we examined the mRNA and protein expression of these proteins using Q-PCR and western blot analysis. As shown in Fig. 11 , Bax mRNA expression was elevated after 12 h and reached a 9-fold significant increase in the experimental groups compared to the control. Bcl-2 mRNA expression was found to decrease in a time-dependent fashion (Fig. 11) . The results of the western blot analysis indicated that the up-regulation of Bax and the down regulation of Bcl-2 are additionally observed on the protein level (Fig. 12 ). These findings demonstrate that HDZC induced apoptosis by altering the regulation of apoptotic-related pro-proteins at both the mRNA and protein levels. 
Cellular Physiology and Biochemistry
The effect of HDZC on p21/p27 expression As accelerators of the cell cycle, cyclin-dependent kinases (CDKs) and their cyclin partners have a pivotal role in cell cycle progression and, accordingly, have been proposed to be key players in the suppression of accelerators [49, 50] . Thus, the activation of cyclin dependent kinase inhibitors (CKIs) effectively adjusts the abnormal proliferation of cancer cells. The CKIs proteins p21 (CIP1) and p27 (KIP1) are members of the CIP/KIP family and are known to form heterotrimeric complexes that promote cell cycle arrest via the G 1 /S CDKs cascade [51] . Because HDZC possessed the ability to induce G 1 cell cycle arrest in MCF7 cells, the next step was to elucidate the possible mechanism behind this outcome and to determine whether it includes the targeted accelerators/inhibitors. Hence, we examined the mRNA and protein expression level of p21 and p27 using Q-PCR and western blot analysis, respectively. The Q-PCR assay showed a significant up-regulation of the mRNA expression of p21 and p27, which reached 2.83 (p21) and 3.57 (p27)-fold higher levels compared to the controls after 48 h of HDZC treatment. As depicted in Fig. 12 , western blot confirmed the perturbations in the mRNA expression of p21 and p27 at the protein level in a time-dependent manner. In sum, the up-regulation of p21 and p27 mediated by the introduction of HDZC treatment is part of the intrinsic pathway governed by mitochondrial genes and leads to the programmed death of cancer cells.
Conclusions
Our study demonstrates the in vivo chemopreventive activity of TPHE. Our results reveal the capability of TPHE to induce apoptosis in LA7-induced tumours in rats accompanied by caspase activation and the up-regulation of Bax and down-regulation of Bcl-2. Moreover, the exposure of tumour cells to TPHE caused cell cycle arrest, as was revealed by p21/p27 protein expression accompanied by p53 activation. The isolation of 8β-hydroxyl-4β, 15-dihydrozaluzanin C sesquiterpene lactone from T. polycephalum is reported, to the best of our knowledge, for the first time. The bioassay guided approach revealed the potent cytotoxic effect of the sesquiterpene lactone. The accumulating body of data has shown the capacity of this class of compounds to act as anti-cancer agents. HDZC displayed a powerful and selective effect on cell survival, life cycles and integrity. In-depth molecular investigations were performed to illustrate the possible mechanisms of action. The elevated activity of caspase 9 associated with the up-regulation of Bax and the down-regulation of Bcl-2 proved that the induction of apoptosis in MCF7 is through the mitochondrial pathway. Additionally, HDZC caused cell cycle arrest at the G 1 phase via alterations of the mRNA and protein expression of p21/p27. Collectively, our work suggests the promise of finding a renewable source of novel anti-cancer therapeutic agents from medicinal plants.
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